163 related articles for article (PubMed ID: 16340081)
1. Using proteomics and network analysis to elucidate the consequences of synaptic protein oxidation in a PS1 + AbetaPP mouse model of Alzheimer's disease.
Soreghan BA; Lu BW; Thomas SN; Duff K; Rakhmatulin EA; Nikolskaya T; Chen T; Yang AJ
J Alzheimers Dis; 2005 Dec; 8(3):227-41. PubMed ID: 16340081
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's disease and amyloid: culprit or coincidence?
Skaper SD
Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
[TBL] [Abstract][Full Text] [Related]
3. Effects of increased iron intake during the neonatal period on the brain of adult AbetaPP/PS1 transgenic mice.
Fernandez LL; Carmona M; Portero-Otin M; Naudi A; Pamplona R; Schröder N; Ferrer I
J Alzheimers Dis; 2010; 19(3):1069-80. PubMed ID: 20157260
[TBL] [Abstract][Full Text] [Related]
4. β-Asarone inhibits neuronal apoptosis via the CaMKII/CREB/Bcl-2 signaling pathway in an in vitro model and AβPP/PS1 mice.
Wei G; Chen YB; Chen DF; Lai XP; Liu DH; Deng RD; Zhou JH; Zhang SX; Li YW; Lii H; Liu LF; Wang Q; Nie H
J Alzheimers Dis; 2013; 33(3):863-80. PubMed ID: 23064259
[TBL] [Abstract][Full Text] [Related]
5. Increased astroglial activity and reduced neuronal function across brain in AβPP-PS1 mouse model of Alzheimer's disease.
Patel AB; Tiwari V; Veeraiah P; Saba K
J Cereb Blood Flow Metab; 2018 Jul; 38(7):1213-1226. PubMed ID: 28585882
[TBL] [Abstract][Full Text] [Related]
6. Early Presymptomatic Changes in the Proteome of Mitochondria-Associated Membrane in the APP/PS1 Mouse Model of Alzheimer's Disease.
Völgyi K; Badics K; Sialana FJ; Gulyássy P; Udvari EB; Kis V; Drahos L; Lubec G; Kékesi KA; Juhász G
Mol Neurobiol; 2018 Oct; 55(10):7839-7857. PubMed ID: 29468564
[TBL] [Abstract][Full Text] [Related]
7. Pyruvate carboxylase and pentose phosphate fluxes are reduced in AβPP-PS1 mouse model of Alzheimer's disease: a ¹³C NMR study.
Tiwari V; Patel AB
J Alzheimers Dis; 2014; 41(2):387-99. PubMed ID: 24625793
[TBL] [Abstract][Full Text] [Related]
8. Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer's disease mice at its earliest pathological stage.
Shen L; Chen C; Yang A; Chen Y; Liu Q; Ni J
J Proteomics; 2015 Jun; 123():101-13. PubMed ID: 25890254
[TBL] [Abstract][Full Text] [Related]
9. Molecular and functional signatures in a novel Alzheimer's disease mouse model assessed by quantitative proteomics.
Kim DK; Park J; Han D; Yang J; Kim A; Woo J; Kim Y; Mook-Jung I
Mol Neurodegener; 2018 Jan; 13(1):2. PubMed ID: 29338754
[TBL] [Abstract][Full Text] [Related]
10. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer's Disease.
Ali T; Kim T; Rehman SU; Khan MS; Amin FU; Khan M; Ikram M; Kim MO
Mol Neurobiol; 2018 Jul; 55(7):6076-6093. PubMed ID: 29170981
[TBL] [Abstract][Full Text] [Related]
11. L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer's transgenic mice.
Peng Y; Hu Y; Xu S; Li P; Li J; Lu L; Yang H; Feng N; Wang L; Wang X
J Alzheimers Dis; 2012; 29(2):379-91. PubMed ID: 22233765
[TBL] [Abstract][Full Text] [Related]
12. Amyloid-beta deposition is associated with decreased hippocampal glucose metabolism and spatial memory impairment in APP/PS1 mice.
Sadowski M; Pankiewicz J; Scholtzova H; Ji Y; Quartermain D; Jensen CH; Duff K; Nixon RA; Gruen RJ; Wisniewski T
J Neuropathol Exp Neurol; 2004 May; 63(5):418-28. PubMed ID: 15198121
[TBL] [Abstract][Full Text] [Related]
13. Nitrosylation of Vesicular Transporters in Brain of Amyloid Precursor Protein/Presenilin 1 Double Transgenic Mice.
Wang Y; Zhou Z; Tan H; Zhu S; Wang Y; Sun Y; Li XM; Wang JF
J Alzheimers Dis; 2017; 55(4):1683-1692. PubMed ID: 27911305
[TBL] [Abstract][Full Text] [Related]
14. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.
Castegna A; Aksenov M; Aksenova M; Thongboonkerd V; Klein JB; Pierce WM; Booze R; Markesbery WR; Butterfield DA
Free Radic Biol Med; 2002 Aug; 33(4):562-71. PubMed ID: 12160938
[TBL] [Abstract][Full Text] [Related]
15. The molecular bases of Alzheimer's disease and other neurodegenerative disorders.
Maccioni RB; Muñoz JP; Barbeito L
Arch Med Res; 2001; 32(5):367-81. PubMed ID: 11578751
[TBL] [Abstract][Full Text] [Related]
16. Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice.
Dewachter I; Reversé D; Caluwaerts N; Ris L; Kuipéri C; Van den Haute C; Spittaels K; Umans L; Serneels L; Thiry E; Moechars D; Mercken M; Godaux E; Van Leuven F
J Neurosci; 2002 May; 22(9):3445-53. PubMed ID: 11978821
[TBL] [Abstract][Full Text] [Related]
17. Novel object recognition as a facile behavior test for evaluating drug effects in AβPP/PS1 Alzheimer's disease mouse model.
Zhang R; Xue G; Wang S; Zhang L; Shi C; Xie X
J Alzheimers Dis; 2012; 31(4):801-12. PubMed ID: 22710911
[TBL] [Abstract][Full Text] [Related]
18. Genetic Deletion of Tumor Necrosis Factor-α Attenuates Amyloid-β Production and Decreases Amyloid Plaque Formation and Glial Response in the 5XFAD Model of Alzheimer's Disease.
Paouri E; Tzara O; Zenelak S; Georgopoulos S
J Alzheimers Dis; 2017; 60(1):165-181. PubMed ID: 28826177
[TBL] [Abstract][Full Text] [Related]
19. Peripheral amyloid levels present gender differences associated with aging in AβPP/PS1 mice.
Ordóñez-Gutiérrez L; Antón M; Wandosell F
J Alzheimers Dis; 2015; 44(4):1063-8. PubMed ID: 25408213
[TBL] [Abstract][Full Text] [Related]
20. Conditional inactivation of nicastrin restricts amyloid deposition in an Alzheimer's disease mouse model.
Sesele K; Thanopoulou K; Paouri E; Tsefou E; Klinakis A; Georgopoulos S
Aging Cell; 2013 Dec; 12(6):1032-40. PubMed ID: 23826707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
